Search
for

    Sort by

    Research 751–780 of 1000+

    1. Novel type 1 5a-reductase Inhibitors with Antiproliferative Potential on LNCaP cells 2023
    2. Design, synthesis and anti-tumor evaluation of novel thiohydantoin congeners as androgen receptor antagonists with in vivo study. Journal of molecular structure · 2024
    3. Reply by the authors Urology · 2004
    4. An overview on 5α-reductase inhibitors Steroids · 2009 · 219 citations
    5. Cognitive dysfunction following finasteride use: a disproportionality analysis of the global pharmacovigilance database Expert Opinion on Drug Safety · 2023
    6. BPH: costs and treatment outcomes. PubMed · 2006 · 34 citations
    7. Editorial Comment Urology · 2013 · 3 citations
    8. Editorial Comment Urology · 2013 · 1 citations
    9. Editorial Comment 2021
    10. Editorial Comment Urology · 2013
    11. Editorial Comment Urology · 2012 · 1 citations
    12. Finasteride: the first 5 alpha-reductase inhibitor. PubMed · 1993 · 34 citations
    13. Chemopr�vention des Prostatakarzinoms Der Urologe · 2004 · 12 citations
    14. Metallothionein expression during wool follicle development in foetal sheep Birkhäuser Basel eBooks · 1999
    15. Bioprospecting of Potential Inhibitors of 5alpha Reductase 2 Inhibitors from Relevant Ethno-pharmacological Plants via In Silico Techniques Scientific African · 2024
    16. Determination of concentrations of sex steroids in blood plasma and semen of male dogs treated with delmadinone acetate or finasteride. PubMed · 2001 · 4 citations
    17. Biomarker-based methods for determining noncompliance in a prevention trial Controlled Clinical Trials · 2002 · 11 citations
    18. 17-Oximino-5-androsten-3β-yl esters: synthesis, antiproliferative activity, acute toxicity, and effect on serum androgen level Medicinal Chemistry Research · 2010 · 7 citations
    19. Novel C-6 substituted and unsubstituted pregnane derivatives as 5α-reductase inhibitors and their effect on hamster flank organs diameter size Steroids · 2009 · 15 citations
    20. Prevalent decrease of the EGF content in the periurethral zone of BPH tissue induced by treatment with finasteride or flutamide. PubMed · 1997 · 7 citations
    21. Biotransformation of Finasteride (MK-0906) by Selenastrum capricornutum (Green Algae) Annals of the New York Academy of Sciences · 2006 · 1 citations
    22. How Much Worse Will My Voiding Symptoms Get over Time? The Journal of Urology · 2013
    23. Abstract ED05-04: Presurgical models to effectively screen preventive agents Cancer Prevention Research · 2010
    24. Androgen Receptor in Human Health: A Potential Therapeutic Target Current Drug Targets · 2012 · 12 citations
    25. Post-finasteride syndrome: An emerging clinical problem Neurobiology of Stress · 2019 · 26 citations
    26. Validated HPTLC method for the simultaneous determination of alfuzosin, terazosin, prazosin, doxazosin and finasteride in pharmaceutical formulations Analytical Chemistry Research · 2014 · 26 citations
    27. Molecular interactions of progesterone derivatives with 5α-reductase types 1 and 2 and androgen receptors Steroids · 2010 · 19 citations
    28. Crystal Structure of 3-Oxo-4-Aza-5-Alpha-Androstone-17 β-Tert-Butyl Carboxamide with an O···H–(C, N) Acceptor Four-Center Hydrogen Bond Journal of Chemical Crystallography · 2008 · 2 citations
    29. Experimental and theoretical studies on the interaction of finasteride with chitosan-based nanoniosomes Journal of molecular structure · 2024 · 1 citations
    30. 5 Alpha-Reductase Inhibitory Potential of Solanum nigrum Effective for Management of Alopecia 2024